US commits $3B to COVID-19 vaccine supply chain

The U.S. will invest $3 billion in the COVID-19 vaccine supply chain as a part of its efforts to scale up vaccine manufacturing, according to a Sept. 2 White House news briefing.

The funding will help drugmakers establish new production lines and facilities and expand fill and finish capacity.

"This $3 billion investment in our vaccine supply chain will create thousands of good-paying American jobs, help us deliver on the president’s commitment to be the arsenal of vaccines for the world, and strengthen our long-term capabilities to respond to future threats," White House COVID-19 response coordinator Jeff Zients said.

The companies receiving the funding have not been selected yet, but the contracting process will "start across the next several weeks," according to Mr. Zients.

 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.